Page 2 - Japanese (NIKKEI) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Jun 13, 2024

Discover Japanese Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NIKKEI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

42 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

2929

Pharma Foods International
JP¥985.007.4%-48.9%JP¥26.2bn/aPE7.1xn/a2.2%

4559

Zeria Pharmaceutical
JP¥2,078.001.8%-18.7%JP¥89.1bJP¥2,810.00PE11.8xE10.2%2.2%

4151

Kyowa Kirin
JP¥2,747.501.6%-0.6%JP¥1.4tJP¥3,054.17PE17.5xE3.5%2.1%

4536

Santen Pharmaceutical
JP¥1,592.50-1.0%29.8%JP¥564.2bJP¥1,827.00PE21.5xE8.4%2.0%

4553

Towa Pharmaceutical
JP¥3,010.007.1%69.0%JP¥145.6bJP¥3,455.00PE9.2xE-3.5%2.0%

4578

Otsuka Holdings
JP¥6,317.00-1.5%13.6%JP¥3.5tJP¥6,472.73PE24.9xE6.9%1.9%

2309

CMIC HOLDINGS
JP¥2,644.000.2%26.6%JP¥44.7bn/aPE8.4xn/a1.9%

4974

Takara Bio
JP¥1,008.00-0.1%-39.4%JP¥120.8bJP¥1,566.67PE82xE22.1%1.7%

4519

Chugai Pharmaceutical
JP¥4,953.004.1%16.7%JP¥8.2tJP¥5,932.14PE25xE5.3%1.7%

4241

atect
JP¥721.003.0%16.3%JP¥3.4bn/aPS1xn/a1.4%

2342

Trans Genic
JP¥231.00-1.3%-25.2%JP¥3.9bn/aPE958.3xn/a1.3%

4581

Taisho Pharmaceutical Holdings
JP¥8,580.00-0.1%50.0%JP¥703.3bJP¥6,180.00PE83.5xE18.2%1.2%

4568

Daiichi Sankyo Company
JP¥5,422.00-7.0%12.1%JP¥10.7tJP¥6,010.00PE51.6xE20.3%1.1%

4886

ASKA Pharmaceutical HoldingsLtd
JP¥2,399.006.9%78.6%JP¥64.6bJP¥2,733.33PE9xE-2.7%1.0%

4880

CellSource
JP¥1,221.00-0.2%-59.8%JP¥23.7bJP¥1,800.00PE28.5xE19.9%0.4%

4506

Sumitomo Pharma
JP¥342.000.3%-47.4%JP¥133.5bJP¥321.25PB0.9xE91.0%0%

7707

Precision System Science
JP¥190.001.1%-44.4%JP¥5.3bn/aPS1.3xn/a0%

4570

Immuno-Biological Laboratories
JP¥524.005.0%42.4%JP¥4.8bn/aPE26.2xn/a0%
Page 2 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.